Firivumab Antibody
Firivumab (CT-P22) is a human IgG1 monoclonal antibody that neutralizes a broad spectrum of influenza A virus subtypes by targeting hemagglutinin. It has demonstrated protective efficacy in murine models against H1N1 infection, supporting its use in influenza research and therapeutic development.
Product Specifications
Target
Influenza Virus
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Infectious Disease & Virology
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog